好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Paramagnetic Rim Lesions on MRI are Specific for the Presence of Oligoclonal Bands in Multiple Sclerosis
Multiple Sclerosis
MS and CNS Inflammatory Disease Posters (7:00 AM-5:00 PM)
149

To investigate clinical associations of paramagnetic lesion rims using 3T MRI in multiple sclerosis.

Paramagnetic rims (PR) have been observed as a feature of some MS lesions on susceptibility-weighted (T2*) MRI, and are thought to represent compartmentalized intrathecal inflammation.

This is a retrospective analysis of patients at a single neuroimmunology clinic.  All patients underwent standardized 3T MRI using a multiecho T2* GRE sequence with susceptibility postprocessing (SWAN protocol, GE).  SWAN phase maps and corresponding FLAIR images were manually reviewed by a rater (CH) initially blinded to clinical data, and iron rims determined based on qualitative assessment of T2* paramagnetic edges on corresponding T2-hyperintense lesions. We used descriptive statistics, t-tests, and chi squares to compare clinical and biological variables with the presence/absence of 1 or more PR. 

Seventy-one MS patients were included in this analysis (N=62 relapsing; 9 progressive). Baseline mean age was 49.5 years, disease duration 10.3 years, and mean EDSS 2.7, with 79% women. 86% were receiving a disease-modifying therapy; 30 patients (42%) had available cerebrospinal fluid (CSF) analysis. 35 of 71 MS patients (49%) had at least 1 PR. PRs did not vary by sex or EDSS but were associated with a younger age in this cohort (53.0 vs 45.8 years; p<0.01). PRs were strongly associated with the presence of CSF oligoclonal bands (OCB, chi2=9.13; p=0.003); all cases with at least 1 PR (N=15; 50%) had 2 or more unique OCB; 8 cases with OCB (27%) did not have evidence of a PR. We did not find any associations with PR and quantitative MRI parameters including whole brain volume or subsequent brain atrophy rates (all p<0.05).

The presence of at least one paramagnetic rim has a very high specificity but only modest sensitivity for presence of oligoclonal bands in the CSF.

Authors/Disclosures
Christopher Hemond, MD (University of Massachusetts Memorial Medical Center)
PRESENTER
The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Daniel Reich, MD, PhD (National Institutes of Health, Neuroimmunology Branch, NINDS) Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.